Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on surv...
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
About this item
Full title
Author / Creator
Stupp, Roger, Dr , Hegi, Monika E, PhD , Mason, Warren P, MD , van den Bent, Martin J, MD , Taphoorn, Martin JB , Janzer, Robert C, MD , Ludwin, Samuel K, MD , Allgeier, Anouk, PhD , Fisher, Barbara, MD , Belanger, Karl, MD , Hau, Peter, MD , Brandes, Alba A, MD , Gijtenbeek, Johanna, MD , Marosi, Christine, MD , Vecht, Charles J, MD , Mokhtari, Karima, PhD , Wesseling, Pieter, MD , Villa, Salvador, MD , Eisenhauer, Elizabeth, MD , Gorlia, Thierry, MSc , Weller, Michael, MD , Lacombe, Denis, MD , Cairncross, J Gregory, MD , Mirimanoff, René-Olivier, MD , on behalf of the European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups , the National Cancer Institute of Canada Clinical Trials Group , European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups and National Cancer Institute of Canada Clinical Trials Group
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background In 2004, a randomised phase III trial by the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trials Group (NCIC) reported improved median and 2-year survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy. We re...
Alternative Titles
Full title
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Authors, Artists and Contributors
Author / Creator
Hegi, Monika E, PhD
Mason, Warren P, MD
van den Bent, Martin J, MD
Taphoorn, Martin JB
Janzer, Robert C, MD
Ludwin, Samuel K, MD
Allgeier, Anouk, PhD
Fisher, Barbara, MD
Belanger, Karl, MD
Hau, Peter, MD
Brandes, Alba A, MD
Gijtenbeek, Johanna, MD
Marosi, Christine, MD
Vecht, Charles J, MD
Mokhtari, Karima, PhD
Wesseling, Pieter, MD
Villa, Salvador, MD
Eisenhauer, Elizabeth, MD
Gorlia, Thierry, MSc
Weller, Michael, MD
Lacombe, Denis, MD
Cairncross, J Gregory, MD
Mirimanoff, René-Olivier, MD
on behalf of the European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups
the National Cancer Institute of Canada Clinical Trials Group
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups
National Cancer Institute of Canada Clinical Trials Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_200982797
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200982797
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(09)70025-7
